SOX17 and cholestasis: These results indicate that only a small additional reduction in Sox17 expression, from ∼50% to ∼60%, is enough to impair GB and EHBD development below a threshold where BA and cholestasis-induced hepatitis occur, causing perinatal lethality (Fig. 6E).